Purpose-built for physicians GLP-1s may reduce cardiovascular risk in rheumatoid arthritis treated with JAK inhibitors GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors, according to data presented at the EULAR 2025 Congress
And I started thinking that there was a pattern there that needed to be investigated." Episodes linked to low blood pressure increased By the numbers: After starting GLP-1s, the patients in the study experienced higher rates of dizziness, fainting and other events related to low blood pressure
Sunless tanning options are the safest to consider in the long-term which include spray-on bronzers and stainers
This growth was propelled by the expansion of its development portfolio in cell and gene therapies, as well as advancements in late-stage pharmaceutical pipeline drugs like asundexian and elinzanetant
Referral to NHS-commissioned weight management services, dietetic services, or commercial programmes with evidence of effectiveness (such as those meeting NICE quality standards) should be considered
